Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77


Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem-Like Cell Fate in an Oxygen-Dependent Manner.

Soubéran A, Cappaï J, Chocry M, Nuccio C, Raujol J, Colin C, Lafitte D, Kovacic H, Quillien V, Baeza-Kallee N, Rougon G, Figarella-Branger D, Tchoghandjian A.

Stem Cells. 2019 Jun;37(6):731-742. doi: 10.1002/stem.2997. Epub 2019 Mar 28.


Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients.

Quillien V, Carpentier AF, Gey A, Avril T, Tartour E, Sejalon F, Campillo-Gimenez B, Vauleon E.

Cancer Immunol Immunother. 2019 Jun;68(6):871-882. doi: 10.1007/s00262-019-02317-9. Epub 2019 Mar 4.


Whole transcriptome sequencing and biomineralization gene architecture associated with cultured pearl quality traits in the pearl oyster, Pinctada margaritifera.

Le Luyer J, Auffret P, Quillien V, Leclerc N, Reisser C, Vidal-Dupiol J, Ky CL.

BMC Genomics. 2019 Feb 6;20(1):111. doi: 10.1186/s12864-019-5443-5.


Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF study.

Ursu R, Thomas L, Psimaras D, Chinot O, Le Rhun E, Ricard D, Charissoux M, Cuzzubbo S, Sejalon F, Quillien V, Hoang-Xuan K, Ducray F, Portal JJ, Tibi A, Mandonnet E, Levy-Piedbois C, Vicaut E, Carpentier AF.

Eur J Cancer. 2019 Mar;109:129-136. doi: 10.1016/j.ejca.2018.12.025. Epub 2019 Feb 1.


The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectives.

Azam Z, Quillien V, Wang G, To ST.

Acta Oncol. 2019 Mar;58(3):353-362. doi: 10.1080/0284186X.2018.1551621. Epub 2019 Jan 11. Review.


The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line.

Monnier A, Boniface R, Bouvet R, Etcheverry A, Aubry M, Avril T, Quillien V, Chevet E, Mosser J.

BMC Cancer. 2018 Dec 4;18(1):1213. doi: 10.1186/s12885-018-5094-y.


First French Pilot Quality Assessment of the EndoPredict Test for Early Luminal Breast Carcinoma.

Lehmann-Che J, Miquel C, Wong J, Callens C, Rouleau E, Quillien V, Lozano N, Cayre A, Lacroix L, Bieche I, Bertheau P, Teixeira L, Llorca FP, Lamy PJ, DE Cremoux P; GFCO GROUP.

Anticancer Res. 2018 May;38(5):2909-2914.


Bioactive extracellular compounds produced by the dinoflagellate Alexandrium minutum are highly detrimental for oysters.

Castrec J, Soudant P, Payton L, Tran D, Miner P, Lambert C, Le Goïc N, Huvet A, Quillien V, Boullot F, Amzil Z, Hégaret H, Fabioux C.

Aquat Toxicol. 2018 Jun;199:188-198. doi: 10.1016/j.aquatox.2018.03.034. Epub 2018 Mar 29.


Microplastics Affect Energy Balance and Gametogenesis in the Pearl Oyster Pinctada margaritifera.

Gardon T, Reisser C, Soyez C, Quillien V, Le Moullac G.

Environ Sci Technol. 2018 May 1;52(9):5277-5286. doi: 10.1021/acs.est.8b00168. Epub 2018 Apr 12.


Phenome of pearl quality traits in the mollusc transplant model Pinctada margaritifera.

Ky CL, Quillien V, Broustal F, Soyez C, Devaux D.

Sci Rep. 2018 Feb 1;8(1):2122. doi: 10.1038/s41598-018-20564-1.


Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.


CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.

Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Vauléon E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V.

Clin Cancer Res. 2017 Dec 1;23(23):7360-7374. doi: 10.1158/1078-0432.CCR-17-1549. Epub 2017 Sep 22.


Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.

Quillien V, Lavenu A, Ducray F, Meyronet D, Chinot O, Fina F, Sanson M, Carpentier C, Karayan-Tapon L, Rivet P, Entz-Werle N, Legrain M, Zalcman EL, Levallet G, Escande F, Ramirez C, Chiforeanu D, Vauleon E, Figarella-Branger D.

Cancer Biomark. 2017 Dec 6;20(4):435-441. doi: 10.3233/CBM-170191.


Long dsRNAs promote an anti-viral response in Pacific oyster hampering ostreid herpesvirus 1 replication.

Pauletto M, Segarra A, Montagnani C, Quillien V, Faury N, Le Grand J, Miner P, Petton B, Labreuche Y, Fleury E, Fabioux C, Bargelloni L, Renault T, Huvet A.

J Exp Biol. 2017 Oct 15;220(Pt 20):3671-3685. doi: 10.1242/jeb.156299. Epub 2017 Aug 10.


Endoplasmic reticulum proteostasis in glioblastoma-From molecular mechanisms to therapeutic perspectives.

Obacz J, Avril T, Le Reste PJ, Urra H, Quillien V, Hetz C, Chevet E.

Sci Signal. 2017 Mar 14;10(470). pii: eaal2323. doi: 10.1126/scisignal.aal2323. Review.


Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial.

Quillien V, Lavenu A, Ducray F, Joly MO, Chinot O, Fina F, Sanson M, Carpentier C, Karayan-Tapon L, Rivet P, Entz-Werle N, Legrain M, Zalcman EL, Levallet G, Escande F, Ramirez C, Chiforeanu D, Vauleon E, Figarella-Branger D.

Oncotarget. 2016 Sep 20;7(38):61916-61929. doi: 10.18632/oncotarget.11322.


Reprint of: Signaling the Unfolded Protein Response in primary brain cancers.

Le Reste PJ, Avril T, Quillien V, Morandi X, Chevet E.

Brain Res. 2016 Oct 1;1648(Pt B):542-552. doi: 10.1016/j.brainres.2016.06.021. Epub 2016 Jun 27. Review.


Signaling the Unfolded Protein Response in primary brain cancers.

Le Reste PJ, Avril T, Quillien V, Morandi X, Chevet E.

Brain Res. 2016 Jul 1;1642:59-69. doi: 10.1016/j.brainres.2016.03.015. Epub 2016 Mar 23. Review.


Oyster reproduction is affected by exposure to polystyrene microplastics.

Sussarellu R, Suquet M, Thomas Y, Lambert C, Fabioux C, Pernet ME, Le Goïc N, Quillien V, Mingant C, Epelboin Y, Corporeau C, Guyomarch J, Robbens J, Paul-Pont I, Soudant P, Huvet A.

Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):2430-5. doi: 10.1073/pnas.1519019113. Epub 2016 Feb 1.


A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.

Beauchesne P, Quillien V, Faure G, Bernier V, Noel G, Quetin P, Gorlia T, Carnin C, Pedeux R.

Int J Cancer. 2016 Mar 15;138(6):1538-44. doi: 10.1002/ijc.29898. Epub 2015 Nov 20.


IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.

Amelot A, De Cremoux P, Quillien V, Polivka M, Adle-Biassette H, Lehmann-Che J, Françoise L, Carpentier AF, George B, Mandonnet E, Froelich S.

PLoS One. 2015 Jul 9;10(7):e0130596. doi: 10.1371/journal.pone.0130596. eCollection 2015.


Disruption of amylase genes by RNA interference affects reproduction in the Pacific oyster Crassostrea gigas.

Huvet A, Béguel JP, Cavaleiro NP, Thomas Y, Quillien V, Boudry P, Alunno-Bruscia M, Fabioux C.

J Exp Biol. 2015 Jun;218(Pt 11):1740-7. doi: 10.1242/jeb.116699. Epub 2015 Apr 16.


DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.

Etcheverry A, Aubry M, Idbaih A, Vauleon E, Marie Y, Menei P, Boniface R, Figarella-Branger D, Karayan-Tapon L, Quillien V, Sanson M, de Tayrac M, Delattre JY, Mosser J.

PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.


Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V.

J Proteomics. 2014 Oct 14;110:7-19. doi: 10.1016/j.jprot.2014.07.022. Epub 2014 Aug 1.


A microarray-based analysis of gametogenesis in two Portuguese populations of the European clam Ruditapes decussatus.

de Sousa JT, Milan M, Bargelloni L, Pauletto M, Matias D, Joaquim S, Matias AM, Quillien V, Leitão A, Huvet A.

PLoS One. 2014 Mar 18;9(3):e92202. doi: 10.1371/journal.pone.0092202. eCollection 2014.


Contrasted survival under field or controlled conditions displays associations between mRNA levels of candidate genes and response to OsHV-1 infection in the Pacific oyster Crassostrea gigas.

Normand J, Li R, Quillien V, Nicolas JL, Boudry P, Pernet F, Huvet A.

Mar Genomics. 2014 Jun;15:95-102. doi: 10.1016/j.margen.2014.02.002. Epub 2014 Feb 26.


Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.

Quillien V, Lavenu A, Sanson M, Legrain M, Dubus P, Karayan-Tapon L, Mosser J, Ichimura K, Figarella-Branger D.

J Neurooncol. 2014 Feb;116(3):487-96. doi: 10.1007/s11060-013-1332-y. Epub 2014 Jan 14.


Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas.

de Tayrac M, Saikali S, Aubry M, Bellaud P, Boniface R, Quillien V, Mosser J.

PLoS One. 2013 Sep 11;8(9):e73332. doi: 10.1371/journal.pone.0073332. eCollection 2013.


Sex-specific regulation of AMP-activated protein kinase (AMPK) in the Pacific oyster Crassostrea gigas.

Guévélou E, Huvet A, Galindo-Sánchez CE, Milan M, Quillien V, Daniel JY, Quéré C, Boudry P, Corporeau C.

Biol Reprod. 2013 Oct 31;89(4):100. doi: 10.1095/biolreprod.113.109728. Print 2013 Oct.


Proteomic analysis of glioblastomas: what is the best brain control sample?

Lemée JM, Com E, Clavreul A, Avril T, Quillien V, de Tayrac M, Pineau C, Menei P.

J Proteomics. 2013 Jun 24;85:165-73. doi: 10.1016/j.jprot.2013.04.031. Epub 2013 May 4.


Regulation of a truncated isoform of AMP-activated protein kinase α (AMPKα) in response to hypoxia in the muscle of Pacific oyster Crassostrea gigas.

Guévélou E, Huvet A, Sussarellu R, Milan M, Guo X, Li L, Zhang G, Quillien V, Daniel JY, Quéré C, Boudry P, Corporeau C.

J Comp Physiol B. 2013 Jul;183(5):597-611. doi: 10.1007/s00360-013-0743-6. Epub 2013 Jan 25.


Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.

Eimer S, Dugay F, Airiau K, Avril T, Quillien V, Belaud-Rotureau MA, Belloc F.

Neuro Oncol. 2012 Dec;14(12):1441-51. doi: 10.1093/neuonc/nos266. Epub 2012 Oct 26.


Study of the antioxidant capacity in gills of the Pacific oyster Crassostrea gigas in link with its reproductive investment.

Béguel JP, Huvet A, Quillien V, Lambert C, Fabioux C.

Comp Biochem Physiol C Toxicol Pharmacol. 2013 Jan;157(1):63-71. doi: 10.1016/j.cbpc.2012.10.004. Epub 2012 Oct 13.


Immune genes are associated with human glioblastoma pathology and patient survival.

Vauléon E, Tony A, Hamlat A, Etcheverry A, Chiforeanu DC, Menei P, Mosser J, Quillien V, Aubry M.

BMC Med Genomics. 2012 Sep 14;5:41. doi: 10.1186/1755-8794-5-41.


Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E.

Oncoimmunology. 2012 May 1;1(3):326-333.


Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients.

Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussière M, Lesimple T, Chinot O, Wager M, Honnorat J, Saikali S, Fina F, Sanson M, Figarella-Branger D.

Cancer. 2012 Sep 1;118(17):4201-11. doi: 10.1002/cncr.27392. Epub 2012 Jan 31.


[Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab].

Vauleon E, Mesbah H, Gedouin D, Lecouillard I, Louvel G, Hamlat A, Riffaud L, Carsin B, Quillien V, Audrain O, Lesimple T.

Bull Cancer. 2012 Feb 1;99(2):121-6. doi: 10.1684/bdc.2011.1528. French.


In vivo RNA interference of a gonad-specific transforming growth factor-β in the Pacific oyster Crassostrea gigas.

Huvet A, Fleury E, Corporeau C, Quillien V, Daniel JY, Riviere G, Boudry P, Fabioux C.

Mar Biotechnol (NY). 2012 Aug;14(4):402-10. doi: 10.1007/s10126-011-9421-4. Epub 2011 Dec 7.


Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).

Godey F, Leveque J, Tas P, Gandon G, Poree P, Mesbah H, Lavoue V, Quillien V, Athias CB.

Breast Cancer Res Treat. 2012 Jan;131(2):509-16. doi: 10.1007/s10549-011-1808-4. Epub 2011 Oct 13.


Isolation of a new cell population in the glioblastoma microenvironment.

Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J; Grand Ouest Glioma Project Network, Menei P.

J Neurooncol. 2012 Feb;106(3):493-504. doi: 10.1007/s11060-011-0701-7. Epub 2011 Sep 18.


Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V.

Brain Pathol. 2012 Mar;22(2):159-74. doi: 10.1111/j.1750-3639.2011.00515.x. Epub 2011 Sep 16.


Mechanisms of immunomodulation in human glioblastoma.

Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V.

Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39. Review.


Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Hamlat A, Mosser J, Quillien V.

Proteome Sci. 2011 Apr 6;9(1):16. doi: 10.1186/1477-5956-9-16.


[MGMT analysis in gliomas].

Quillien V, Vauléon E, Saikali S, Lesimple T, Hamlat A, Etcheverry A, Mosser J.

Bull Cancer. 2011 Mar;98(3):291-303. doi: 10.1684/bdc.2011.1332. Review. French.


A 4-gene signature associated with clinical outcome in high-grade gliomas.

de Tayrac M, Aubry M, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J.

Clin Cancer Res. 2011 Jan 15;17(2):317-27. doi: 10.1158/1078-0432.CCR-10-1126. Epub 2011 Jan 11.


DNA methylation in glioblastoma: impact on gene expression and clinical outcome.

Etcheverry A, Aubry M, de Tayrac M, Vauleon E, Boniface R, Guenot F, Saikali S, Hamlat A, Riffaud L, Menei P, Quillien V, Mosser J.

BMC Genomics. 2010 Dec 14;11:701. doi: 10.1186/1471-2164-11-701.


Overview of cellular immunotherapy for patients with glioblastoma.

Vauleon E, Avril T, Collet B, Mosser J, Quillien V.

Clin Dev Immunol. 2010;2010. pii: 689171. doi: 10.1155/2010/689171. Epub 2010 Oct 4. Review.


Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.

Avril T, Saikali S, Vauleon E, Jary A, Hamlat A, De Tayrac M, Mosser J, Quillien V.

J Neuroimmunol. 2010 Aug 25;225(1-2):22-33. doi: 10.1016/j.jneuroim.2010.04.003. Epub 2010 May 20.


[Epigenetic regulation in glioblastomas].

Quillien V.

Ann Pathol. 2009 Nov;29 Spec No 1:S34-6. doi: 10.1016/j.annpat.2009.07.014. Epub 2009 Oct 2. Review. French. No abstract available.


Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.

Karayan-Tapon L, Quillien V, Guilhot J, Wager M, Fromont G, Saikali S, Etcheverry A, Hamlat A, Loussouarn D, Campion L, Campone M, Vallette FM, Gratas-Rabbia-Ré C.

J Neurooncol. 2010 May;97(3):311-22. doi: 10.1007/s11060-009-0031-1. Epub 2009 Oct 20.


Supplemental Content

Loading ...
Support Center